Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study is designed to evaluate the safety and efficacy of lefitolimod and 3BNC117/10‐1074 in HIV‐1‐infected individuals on ART and during ATI as intervention to reduce the HIV‐1 reservoir
Epistemonikos ID: 2cf67649053b8b547453a3b5842f3df553a5d55a
First added on: May 22, 2024